Final Open Call from canSERV: More Nodes, More Services

Euro-BioImaging is pleased to announce that the fourth and final Open Call from the Horizon Europe-funded canSERV project is here! Cancer Researchers are invited to apply for FREE state-of-the-art services and training at several European Research Infrastructures, including Euro-BioImaging ERIC. 

Within this project, now 36 Euro-Bioimaging Nodes offer access to their expertise. It’s an amazing opportunity for the cancer research community to access a wide-ranging portfolio of services. More information on participating Nodes, available services and the application process can be found here

canSERV invites applications covering the entire range of the oncology developmental pipeline, from supporting discoveries in fundamental research to translational science and personalised oncology, addressing at least one of the four strategic goals of the Cancer Mission:

• Understanding of Cancer
• Prevention and Early Detection
• Diagnosis and treatment
• Quality of life for patients and their families

Researchers from academia, industry and SMEs may apply for several service categories including: 

1. disease models, 
2. cutting-edge imaging and structural biology technologies, 
3. biomarker research and development, 
4. new therapeutic solutions, 
5. complex clinical trial design and support, 
6. personalised oncology implementation pipelines and recommendations and 
7. regulatory support and tools to analyse the socioeconomic dimension of research activities. 

Submission deadline is July 15th, 2025 at 14.00 CEST. 

The applications will be reviewed by an international, independent review panel and evaluated for scientific excellence, impact and need for the requested services. 

Applications are reviewed and evaluated as they are received, so all applicants are encouraged to apply early!

For more information and call text please visit the CanSERV project website www.canSERV.eu/Calls or contact us at canservprojects@eurobioimaging.eu. 

About canSERV

As part of a concerted strategy to tackle the challenges of cancer, the EU-funded project canSERV offers more than 400 innovative cancer research technologies to European and non-European cancer researchers at all levels. The service, or a combination of services and training, can be requested to accelerate ground-breaking discoveries and their translation into clinical applications.

In line with Europe’s Cancer Mission and Beating Cancer Plan, canSERV promotes the development of concrete solutions for cancer by providing a comprehensive set of world-class oncology technologies and state of the art training to cancer scientists. 

canSERV Enables Researchers to Cover the Entire Range of the Oncology Developmental Pipeline